Las Vegas, NV -- (SBWIRE) -- 12/19/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Glu Mobile Inc. (NASDAQ:GLUU), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Hanwha Solarone Co Ltd (NASDAQ:HSOL), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)
Glu Mobile Inc. (NASDAQ:GLUU) managed to keep its gain at 0.13% on below -normal volume of 2.15M shares. The stock settled at $3.71 after floating in a range of $3.66 to $3.77. Its latest price has reached market capitalization of $289.22 million. Its 52-week range has been $2to $4.14. Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors.
For How Long GLUU will fight for Profitability? Read This Trend Analysis report
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) traded up on a volume of 2.09 million, lower than its standard daily volume. Shares have gained 0.93% to $4.34. Over the last twelve months, the stock has lost-51.99% and faced a worst price of $3.70. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development.
For How Long SNTA’s Gloss will Attract Investors? Find out via this report
Hanwha Solarone Co Ltd (NASDAQ:HSOL) settled 0.37% higher at $2.72 on above-normal volume of 2.02M shares during the last trading day. The stock has its 12-month high at $5.70 and 52-week low price was $0.86. It traded in a range of $2.66 to $2.86 during the last trading day. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency. The Company also provides PV module processing services.
Why Should Investors Buy HSOL After the Recent Fall? Just Go Here and Find Out
In the last trading session, Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) was up on high volume, trading at a volume of 1.90M versus its average daily volume of 1.52 million shares. At $3.97, the stock has attained market capitalization of 311.38 million. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Will CHTP Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)